ANABOLIC THERAPIES AND THEIR METABOLIC EFFECT IN AIDS

艾滋病中的合成代谢疗法及其代谢作用

• 批准号: 6305581
• 负责人: MORRIS SCHAMBELAN
• 金额: $ 0.06万
• 依托单位: UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
• 依托单位国家: 美国
• 财政年份: 1999
• 资助国家: 美国
• 起止时间: 1999-12-01 至 2000-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6305581
• 关键词: AIDS; AIDS therapy; HIV infections; androgen analog; cachexia; carbohydrate metabolism; clinical research; electrolyte balance; hormone regulation /control mechanism; hormone therapy; human subject; human therapy evaluation; insulinlike growth factor; lipid metabolism; metabolism disorder; metabolism disorder chemotherapy; nitrogen balance; outcomes research; protein metabolism; recombinant proteins; somatotropin; thalidomide

This study is designed to determine the effects of recombinant human growth hormone, insulin-like growth factor I, anabolic steroids, and thalidomide on nitrogen and electrolyte balance, fat, protein, and carbohydrate metabolism in catabolic patients with HIV infection.

这项研究旨在确定重组人类生长激素，胰岛素样生长因子I，合成代谢类固醇和沙利度胺对氮和电解质平衡，脂肪，蛋白质和碳水化合物代谢对HIV感染的分解代谢患者的影响。